Abstract 518P
Background
Artificial Intelligence (AI) holds the promise to transform medicine during diagnosis, management and therapy of diseases. The AICCELERATE project will introduce an operational approach to develop AI-enabled digital solutions to improve medical processes by creating a digital twin. In our study, we performed the first pilot application of the AICCELERATE project at Bambino Gesù Children’s Hospital in Rome (OPBG). The aim of our study is to design a supervised machine learning (ML) model to predict time to surgery and time to diagnosis based (outputs) on time from admission to first consultation and imaging (inputs) in newly diagnosed pediatric patients.
Methods
We included pediatric patients with new diagnoses of brain tumors, treated in OPBG from December 2017 to December 2022. We collected from EHR the following data: age and sex, start and end date of the first admission, department of hospitalization, consultations and radiological imaging date, diagnosis, and surgery date.
Results
We included 48 patients with a pediatric brain tumor, with a mean age of 8.6 years. We used a multiple linear regression model, which does not require large datasets such as more complex models. Our analysis showed that delayed consulting and imaging led to a delayed diagnosis, with the consulting presenting a higher importance than the imaging. This result was validated by the model’s estimated regressors coefficients, with the consulting factor being assigned a larger weight β_C=1.81 than the imaging factor β_I=-0.33. Similarly, we observed that delayed consulting and imaging led to a delayed surgery, estimating a higher coefficient for the consulting β_C=0.71 than the one estimated for the imaging β_I=-0.06. While the ML model achieved a reasonable performance in both frameworks, the time to surgery was predicted with a lower MAE 4.45±0.87 compared to the diagnosis MAE of 6.74±0.95.
Conclusions
This preliminary study conducted in a small number of patients, suggests that decreasing time to consultation can shorten time to surgery in children with brain cancer. As the AICCELERATE is ongoing, more accurate models will be developed and will help to better understand how to optimize the journey of children with brain cancer.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
529P - Post-marketing surveillance data from patients ≥70 years of age with central nervous system malignancies treated with Tumor Treating Fields (TTFields) therapy between 2011–2022
Presenter: Wenyin Shi
Session: Poster session 10
530P - Ultra low bevacizumab (BEVULTRA-100) as a novel approach in symptomatic management of high grade glioma: Can minimal dose make a difference?
Presenter: P ANURADHA
Session: Poster session 10
531P - Tumor treating fields therapy for glioblastoma: Identifying needs and satisfaction of new and long-term users
Presenter: Eleni T. Batzianouli
Session: Poster session 10
532P - Nitric oxide is a target by a combo-drug for glioblastoma treatment
Presenter: Manish Tripathi
Session: Poster session 10
533P - Oligodendrogliomas: What is the impact after the introduction of the WHO molecular classification?
Presenter: Maria Angeles Vaz Salgado
Session: Poster session 10
534P - Glioblastoma treatment in patients older than 60 years: Hypofractionated radiotherapy and temozolomide versus conventional radiotherapy and temozolomide
Presenter: Teresa Pacheco
Session: Poster session 10
535P - Hypofractionated radiotherapy in fit elderly patients with glioblastoma: Relevant or detrimental?
Presenter: Carla Martín Abreu
Session: Poster session 10
536P - Safety and efficacy of silibinin in patients with brain metastases after stereotactic radiosurgery (SRS): The SUSTAIN trial
Presenter: Niccolò Bertini
Session: Poster session 10
537P - S100A9 serum levels are associated with survival prognosis in patients with brain metastases
Presenter: Ariane Steindl
Session: Poster session 10
538P - Single-center retrospective analysis of patients with brain metastases included in early phase clinical trials
Presenter: Giulia Pretelli
Session: Poster session 10